|
|||||
|
|
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides |
|
| Authors: | B.A. Tjoa S.J. Simmons V.A. Bowes H. Ragde M. Rogers A. Elgamal G.M. Kenny O.E. Cobb R.C. Ireton M.J. Troychak M.L. Salgaller A.L. Boynton G.P. Murphy |
| Abstract: | |
| Keywords: | dendritic cells prostate-specific membrane antigen T cell immunotherapy prostate cancer clinical trial long period of evaluation |